lidoflazine has been researched along with Brain Neoplasms in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, J | 1 |
| Kang, H | 1 |
| Son, B | 1 |
| Kim, MJ | 1 |
| Kang, J | 1 |
| Park, KH | 1 |
| Jeon, J | 1 |
| Jo, S | 1 |
| Kim, HY | 1 |
| Youn, H | 1 |
| Youn, B | 1 |
1 other study available for lidoflazine and Brain Neoplasms
| Article | Year |
|---|---|
NRBF2-mediated autophagy contributes to metabolite replenishment and radioresistance in glioblastoma.
Topics: Animals; Autophagy; Autophagy-Related Proteins; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Di | 2022 |